CA
MD icon

Clearstead Advisors’s Pediatrix Medical MD Stock Holding History

Clearstead Advisors’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.5K Buy
3,376
+8
+0.2% +$182 ﹤0.01% 1337
2026
Q1 		$72K Hold
3,368
– – ﹤0.01% 1217
2025
Q4 		$72K Buy
3,368
+2,964
+734% +$60.7K ﹤0.01% 1240
2025
Q3 		$6.77K Buy
404
+72
+22% +$1.08K ﹤0.01% 2052
2025
Q2 		$4.76K Buy
+332
New +$4.55K ﹤0.01% 2122
2024
Q4 		– Sell
-703
Closed -$8.15K – 2153
2024
Q3 		$8.15K Hold
703
– – ﹤0.01% 1622
2024
Q2 		$5.31K Buy
+703
New +$5.82K ﹤0.01% 1680

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Clearstead Advisors's MD Position: Q2 2026 in Review

Clearstead Advisors increased its Pediatrix Medical (MD) stake by 0.24% in Q2 2026, buying an estimated $182 and bringing the position to 3,376 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Clearstead Advisors first reported a position in MD in Q2 2024 and has held it in 7 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Clearstead Advisors held 3,376 shares of Pediatrix Medical worth $85.5K as of Q2 2026.
  • Clearstead Advisors bought 8 Pediatrix Medical shares in Q2 2026, an estimated $182.
  • Pediatrix Medical made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1337 holding.
  • Clearstead Advisors first reported a position in Pediatrix Medical in Q2 2024 and has held it in 7 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.